---
figid: PMC6873089__lic-0008-0341-g02
figtitle: Mutational landscape of HCC
organisms:
- NA
pmcid: PMC6873089
filename: lic-0008-0341-g02.jpg
figlink: pmc/articles/PMC6873089/figure/F2/
number: F2
caption: Mutational landscape of HCC. This figure depicts the main signaling pathways
  mutated in liver carcinogenesis. The main driver genes mutated in HCC in each signaling
  pathway are shown with the percentages of somatic mutations in each gene. Oncogenes
  are presented in red and tumor suppressor genes in blue. TERT, CCNE1, and MLL4 are
  also targeted by recurrent somatic HBV insertions. The TERT gene was either mutated
  in its promoter or amplified (TERT amp.). ALB, albumin; APC, adenomatosis polyposis
  coli tumor suppressor; APOB, apolipoprotein B; ARID2, AT-rich interactive domain-containing
  protein 2; ARIDI1A, AT-rich interactive domain-containing protein 1A; ATM, ataxia-telangiectasia
  mutated; CCNE1, cyclin E1; CDKN2A, cyclin-dependent kinase inhibitor 2A; CTNNB1,
  Catenin (cadherin-associated protein) beta 1; FBG, fibrinogen beta chain; FGF19,
  fibroblast growth factor 19; IL6ST, glycoprotein 130; JAK, janus kinase; KEAP1,
  kelch-like ECH-associated protein 1; MLL, mixed-lineage leukemia; mTOR, mechanistic
  target of rapamycin; NFE2L2, nuclear factor (erythroid-derived 2)-like 2; RB1, retinoblastoma
  protein; PIK2CA, phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit
  alpha; PTEN, phosphatase and tensin homolog; RPS6KA3, ribosomal protein S6 kinase,
  90kDa, polypeptide 3; STAT, signal transducer and activator of transcription; TERT,
  telomerase reverse transcriptase; TP53, tumor protein p53; TSC1/2, tuberous sclerosis
  1/2; VEGFA, vascular endothelial growth factor A.
papertitle: Systemic Treatment for Advanced Hepatocellular Carcinoma.
reftext: Mohamed Bouattour, et al. Liver Cancer. 2019 Oct;8(5):341-358.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8825361
figid_alias: PMC6873089__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6873089__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6873089__lic-0008-0341-g02.html
  '@type': Dataset
  description: Mutational landscape of HCC. This figure depicts the main signaling
    pathways mutated in liver carcinogenesis. The main driver genes mutated in HCC
    in each signaling pathway are shown with the percentages of somatic mutations
    in each gene. Oncogenes are presented in red and tumor suppressor genes in blue.
    TERT, CCNE1, and MLL4 are also targeted by recurrent somatic HBV insertions. The
    TERT gene was either mutated in its promoter or amplified (TERT amp.). ALB, albumin;
    APC, adenomatosis polyposis coli tumor suppressor; APOB, apolipoprotein B; ARID2,
    AT-rich interactive domain-containing protein 2; ARIDI1A, AT-rich interactive
    domain-containing protein 1A; ATM, ataxia-telangiectasia mutated; CCNE1, cyclin
    E1; CDKN2A, cyclin-dependent kinase inhibitor 2A; CTNNB1, Catenin (cadherin-associated
    protein) beta 1; FBG, fibrinogen beta chain; FGF19, fibroblast growth factor 19;
    IL6ST, glycoprotein 130; JAK, janus kinase; KEAP1, kelch-like ECH-associated protein
    1; MLL, mixed-lineage leukemia; mTOR, mechanistic target of rapamycin; NFE2L2,
    nuclear factor (erythroid-derived 2)-like 2; RB1, retinoblastoma protein; PIK2CA,
    phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; PTEN,
    phosphatase and tensin homolog; RPS6KA3, ribosomal protein S6 kinase, 90kDa, polypeptide
    3; STAT, signal transducer and activator of transcription; TERT, telomerase reverse
    transcriptase; TP53, tumor protein p53; TSC1/2, tuberous sclerosis 1/2; VEGFA,
    vascular endothelial growth factor A.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - CDKN2A
  - RB1
  - RBM45
  - TERT
  - APRT
  - MFAP1
  - CCNE1
  - ATM
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AXIN1
  - KMT2A
  - APC
  - PROC
  - ARID2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - FGF19
  - VEGFA
  - NFE2L2
  - KEAP1
  - PIK3CA
  - PTEN
  - KRAS
  - NRAS
  - TSC2
  - TSC1
  - CCL26
  - RPS6KA3
  - IL6ST
  - ALB
  - FBF1
  - FGB
  - JAK1
  - retinoblastoma
  - ARS
---
